News

The finding can reveal how protein transport goes awry in conditions including Alzheimer’s and autism.

The new method by scientists at Scripps Research identifies specific antibodies in immune responses to vaccination or infection in fraction of time needed for traditional approach.

Financial support will fuel fundamental scientific breakthroughs and development of new medicines.

A new antibody discovered in the blood of some people vaccinated against or infected with influenza can recognize a broad variety of flu viruses.

Researchers show how toxic aggregates are formed inside brain cells, and how to block the cell-killing process—which may also be at work in Alzheimer’s and other neurodegenerative diseases.

Experimental drug 3K3A-APC has shown broad brain-protecting effects in animal studies.

Two of the first three patients in the lowest dose cohort experienced a complete response to therapy.

Mobile app-based research platform aims to engage and empower researchers and participants across the country.

Lerner made major scientific contributions and built Scripps Research into a world-renowned hub of innovative science and medicine.

New collection of pain relieving compounds dial down risk of tolerance and breathing suppression while boosting pain control.

Chronic stress and depression boost this unusual brain receptor. A new study maps out its structure to aid drug discovery.

The award supports an innovative project that represents an exciting change in research direction for an early stage investigator.

Study shows how antibodies work in a powerful synergy against major ebolavirus species.

The annual list represents the “who’s who” of influential researchers who have impacted their field over the past decade.

An agreement has been signed to welcome the Florida branch of the science powerhouse into the research arm of UF’s academic health center.

New method for desaturating aliphatic acids overcomes a long-standing challenge in synthetic chemistry.

Study demonstrates a closely related set of chemical reactions that could have supported the development of early life forms.

Boosting CRCT2 in mice counters metabolism-slowing effects of fasting, study finds.

Compound co-opts a natural enzyme to degrade a deadly disease at its source, erasing 70 percent of a toxic protein in mice.

A new chemistry tool offers hope for mitochondiral diseases.

Study suggests the experimental vaccine may engage the immune system much more robustly than other vaccine strategies.

Scripps Research and two other San Diego research institutions each received grants of around $5 million from CIRM to support the training of graduate students, postdoctoral trainees, and clinical trainees.

3-year observational results of novel, home-based clinical trial published in PLOS ONE

Patapoutian is being recognized for his groundbreaking research that solved a long-standing mystery of how the body senses touch and other mechanical stimuli.